Clinical trial
Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure
NCT00633685 is registered in ClinicalTrials.gov with TEMPVA Research Group, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure
- Lead sponsor
- TEMPVA Research Group, Inc.
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 31, 2010
- Completion date
- August 31, 2012
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
posttraumatic stress disorder, combat-related